Drug Profile
Anti-CD19-dsFv-PE38-immunotoxin
Alternative Names: Disulphide-linked anti Cd19 Pseudomonas exotoxin 38Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 May 1999 New profile
- 10 May 1999 Preclinical development for Cancer in USA (Unknown route)